-
Vonoprazan Fumarate CAS 1260141-27-2Vonoprazan Fumarate CAS 1260141-27-2, is a new type of oral potassium-competitive acid blocker that inhibits gastric acid secretion by competitively inhibiting H⁺, K⁺-ATPase (proton pump) in...read more
-
Dotinurad CAS 1285572-51-1Dotinurad CAS 1285572-51-1, is a novel selective urate reabsorption inhibitor (SURI) used for the treatment of hyperuricemia and gout.read more
Indications: Hyperuricemia -
Fenofibrate CAS 49562-28-9Fenofibrate CAS 49562-28-9, is a fibric acid derivative (fibrate) used for the treatment of hyperlipidemia (elevated blood lipids). It is a peroxisome proliferator-activated receptor alpha (PPARα)...read more
-
Pranlukast Hydrate CAS 103177-37-3Pranlukast Hydrate CAS 103177-37-3, is a leukotriene receptor antagonist used for the treatment of asthma and allergic rhinitis.read more
Indications: bronchial asthma, allergic rhinitis, and other... -
Tenoxicam CAS 59804-37-4Tenoxicam CAS 59804-37-4, is a non-steroidal anti-inflammatory drug with analgesic, anti-inflammatory, and antipyretic effects. It belongs to the enolic acid (oxicam) class of NSAIDs and is a...read more
-
Tofacitinib Citrate CAS 540737-29-9Tofacitinib Citrate CAS 540737-29-9, is a Janus kinase (JAK) inhibitor that is administered orally and has immunomodulatory and anti-inflammatory effects. It is a citrate formed by combining...read more
-
Doravirine CAS 1338225-97-0Doravirine CAS 1338225-97-0, is a new generation non-nucleoside reverse transcriptase inhibitor (NNRTI) used for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. Due to its...read more
-
Elsulfavirine Potassium CAS 868046-19-9Elsulfavirine Potassium CAS 868046-19-9, is a new generation non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat human immunodeficiency virus type 1 (HIV-1)...read more
-
Tenapanor Hcl CAS 1234365-97-9Tenapanor Hcl CAS 1234365-97-9, is a sodium/hydrogen exchanger isoform 3 (NHE3) inhibitor, treatment of hyperphosphatemia and Irritable Bowel Syndrome with Constipation (IBS-C).read more
Vonoprazan Fumarate | C21H20FN3O6S | CID 45375887 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological ......
Vonoprazan fumarate equivalent to Vonoprazan…20mg CLINICAL PHARMACOLOGY Mechanism of Action Vonoprazan is a potassium competitive acid blocker (P-CAB) and does not require...
Dosis Vonoprazan Dewasa. → 20 mg 1 x / hr selama 4 minggu, dapat dilanjutkan 4 minggu lagi jika diperlukan. → Pemeliharaan penyembuhan untuk refluks esofagitis berulang: 10 mg 1 x /...
Vonoprazan-d3 (fumarate) | C21H20FN3O6S | CID 163409214 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological ......
Apr 15, 2020 · Potassium-competitive acid blockers (P-CABs), such as vonoprazan, represent a novel and heterogeneous class of drugs that competitively block the potassium binding site of...
vonoprazan fumarate (takecab ®), discovered and developed by takeda and otsuka, was approved by the pmda of japan in december 2014, and is indicated for the treatment of gastric...
